POV-10 Estudio para potencializar la acción multidiana frente a lipasa pancreática y α-glucosidasa de las xantonas provenientes de Garcinia mangostana.
DOI:
https://doi.org/10.3407/rpn.v5i2.6823Palavras-chave:
Obesidad, enzimas digestivas, inhibición enzimática, polifarmacológicoResumo
Las enzimas digestivas lipasa pancreática y α-glucosidasa, son importantes en el metabolismo de lípidos y carbohidratos, convirtiéndose en blancos terapéuticos atractivos para el tratamiento de la obesidad y patologías asociadas.
Referências
. Adnyana IK, Abuzaid AS, Iskandar EY, Kurniati NF (2016) Pancreatic lipase and α-amylase inhibitory potential of mangosteen ( Garcinia Mangostana Linn.) pericarp extract. Int J Med Res Heal Sci 5(1):23.
. Chae HS, et al. (2016) Xanthones with pancreatic lipase inhibitory activity from the pericarps of Garcinia mangostana L. (Guttiferae). Eur J Lipid Sci Technol 118(9):1416–1421.
. Martinez-Gonzalez AI, et al. (2017) In vitro inhibition of pancreatic lipase by polyphenols: A kinetic, Fluorescence spectroscopy and molecular docking study. Food Technol Biotechnol 55(4):519–530.
. Ye GJ, et al. (2019) Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion. Eur J Med Chem 177:362–373.
Downloads
Publicado
Edição
Seção
Categorias
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.